Idiopathic neuropathy patients are at high risk for metabolic syndrome.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMC 2576295)

Published in J Neurol Sci on July 07, 2008

Authors

A Gordon Smith1, Kristi Rose, J Robinson Singleton

Author Affiliations

1: Department of Neurology, University of Utah, United States. Gordon.smith@hsc.utah.edu

Articles citing this

Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol (2012) 1.99

Corneal confocal microscopy: a novel means to detect nerve fibre damage in idiopathic small fibre neuropathy. Exp Neurol (2009) 1.50

Obesity and hyperlipidemia are risk factors for early diabetic neuropathy. J Diabetes Complications (2013) 1.07

Peripheral vascular disease and peripheral neuropathy in individuals with cardiometabolic clustering and obesity: National Health and Nutrition Examination Survey 2001-2004. Diabetes Care (2011) 0.99

The metabolic syndrome and neuropathy: therapeutic challenges and opportunities. Ann Neurol (2013) 0.96

Diabetic neuropathy: one disease or two? Curr Opin Neurol (2012) 0.95

Neuropathy of impaired glucose tolerance and its measurement. Diabetes Care (2010) 0.92

Supervised exercise improves cutaneous reinnervation capacity in metabolic syndrome patients. Ann Neurol (2014) 0.88

Chronic idiopathic axonal polyneuropathy is associated with the metabolic syndrome. Diabetes Care (2012) 0.88

Dyslipidaemia in chronic acquired distal axonal polyneuropathy. J Neurol (2011) 0.86

The epidemiology and risk factors of chronic polyneuropathy. Eur J Epidemiol (2015) 0.81

Relations between metabolic homeostasis, diet, and peripheral afferent neuron biology. Adv Nutr (2014) 0.80

Chronic idiopathic axonal polyneuropathy: a systematic review. J Neurol (2016) 0.79

Idiopathic small fiber neuropathy: phenotype, etiologies, and the search for fabry disease. J Clin Neurol (2014) 0.78

Study of Autophagy and Microangiopathy in Sural Nerves of Patients with Chronic Idiopathic Axonal Polyneuropathy. PLoS One (2016) 0.77

High energy diets-induced metabolic and prediabetic painful polyneuropathy in rats. PLoS One (2013) 0.76

Serial anthropometry predicts peripheral nerve dysfunction in a community cohort. Diabetes Metab Res Rev (2013) 0.75

Metabolic Syndrome, Neurotoxic 1-Deoxysphingolipids and Nervous Tissue Inflammation in Chronic Idiopathic Axonal Polyneuropathy (CIAP). PLoS One (2017) 0.75

Gender Differences in Biochemical and Electroneurographic Parameters of Median and Ulnar Nerve. Acta Inform Med (2015) 0.75

Chewing the fat: genetic approaches to model dyslipidemia-induced diabetic neuropathy in mice. Exp Neurol (2013) 0.75

Neuroprotective effect of RYGB in Zucker fatty diabetic rats. Int J Clin Exp Med (2014) 0.75

Solving the riddle of the sphinx may provide new insights into diabetes and polyneuropathy. Diabetes (2015) 0.75

Clinical Characteristics, Electrophysiology, and Skin Biopsy of 38 Peripheral Neuropathy Cases with Small Fiber Involvement of Various Etiologies. Chin Med J (Engl) (2017) 0.75

Articles cited by this

The spread of obesity in a large social network over 32 years. N Engl J Med (2007) 34.75

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA (2002) 25.68

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med (2003) 20.06

Vascular risk factors and diabetic neuropathy. N Engl J Med (2005) 7.69

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev (2002) 4.41

Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care (2006) 3.47

Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care (2001) 2.53

Risk stratification in hypertension: new insights from the Framingham Study. Am J Hypertens (2000) 1.98

Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes (1997) 1.88

Microvascular complications of impaired glucose tolerance. Diabetes (2003) 1.88

Adiponectin: a link between excess adiposity and associated comorbidities? J Mol Med (Berl) (2002) 1.67

A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain (2004) 1.62

Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care (2004) 1.54

Idiopathic neuropathy, prediabetes and the metabolic syndrome. J Neurol Sci (2006) 1.23

Small fiber neuropathy is associated with the metabolic syndrome. Metab Syndr Relat Disord (2005) 1.14

Prevalence of somatic small fiber neuropathy in obesity. Int J Obes (Lond) (2006) 1.01

Impact of obesity on neuropathic late complications in NIDDM. Diabetes Care (1994) 0.96

Free fatty acid overload attenuates Ca2+ signaling and NO production in endothelial cells. Antioxid Redox Signal (2003) 0.92

FFA-induced endothelial dysfunction can be corrected by vitamin C. J Clin Endocrinol Metab (2002) 0.88

Impact of body mass on autonomic function in persons with type 2 diabetes. Diabetes Res Clin Pract (1999) 0.80